Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

496
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
496
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

386
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
386
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

432
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
432
Glucose Transporters01:27

Glucose Transporters

22.4K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.4K
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

5.6K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
5.6K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

149
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
149

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gut microbiota dysbiosis and osteoporosis: pathogenesis and novel intervention strategies.

Future microbiology·2026
Same author

Gut microbiota impact on lung diseases: a mini review of clinical evidence.

Infection and immunity·2026
Same author

Letter to the Editor: Comparative Efficacy and Safety of 0.8-L Versus 2-LPolyethylene Glycol-Ascorbic Acid Solutions in ColonoscopyPreparation: A Prospective, Multicenter, Randomized, and Controlled Trial.

Journal of gastroenterology and hepatology·2026
Same author

Early-Life Body Mass Index and Inflammatory Bowel Disease Risk: A Scandinavian Birth Cohort Study.

Inflammatory bowel diseases·2025
Same author

Letter to the Editor: Pre-Treatment Liver Stiffness Is a Stronger Predictor of Hepatocellular Carcinoma Development Than Post-Treatment Liver Stiffness After Hepatitis C Virus Eradication.

Hepatology research : the official journal of the Japan Society of Hepatology·2025
Same author

Emerging roles of the immune microenvironment in glaucoma.

Clinical & experimental optometry·2025

Related Experiment Video

Updated: May 28, 2025

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.3K

Metabolic dysregulation in glaucoma.

Xirui Yang1, Songwei Li2, Hao Guo1

  • 1Department of Ophthalmology, First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.

Clinical & Experimental Optometry
|February 12, 2025
PubMed
Summary

Metabolic dysregulation, including issues with energy production and nutrient processing, significantly contributes to glaucoma, a leading cause of blindness. Understanding these metabolic changes offers new therapeutic targets for this complex neurodegenerative disease.

Keywords:
Glaucomametabolic dysregulationretinal ganglion cells

More Related Videos

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice
09:26

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

Published on: March 23, 2016

19.3K
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.0K

Related Experiment Videos

Last Updated: May 28, 2025

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.3K
A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice
09:26

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

Published on: March 23, 2016

19.3K
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.0K

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Metabolic Research

Background:

  • Glaucoma is a leading cause of irreversible blindness globally, characterized by retinal ganglion cell (RGC) loss.
  • Metabolic dysregulation is increasingly recognized as a critical factor in glaucoma's development and progression.

Purpose of the Study:

  • To review the complex relationship between metabolic processes and glaucoma.
  • To highlight key mechanisms including mitochondrial, lipid, and glucose metabolism in RGCs.
  • To explore the role of specific metabolites and their dysregulation in glaucomatous damage.

Main Methods:

  • Literature review focusing on metabolic pathways in glaucoma.
  • Analysis of studies on mitochondrial function, lipid metabolism, and glucose metabolism in RGCs.
  • Examination of the interplay between metabolic changes, intraocular pressure, and ocular blood flow.

Main Results:

  • Mitochondrial dysfunction impairs energy production, compromising RGC viability.
  • Altered lipid metabolism and peroxidation contribute to RGC injury and apoptosis.
  • Disturbances in glucose metabolism reduce energy and neurotrophic support essential for RGC survival.
  • Dysregulated metabolites like lactate and glutamate exacerbate glaucomatous damage.

Conclusions:

  • Metabolic dysregulation is a key driver of RGC neurodegeneration in glaucoma.
  • Understanding these metabolic pathways provides a foundation for novel therapeutic strategies.
  • Targeting metabolic dysfunction may offer new avenues for treating glaucoma and improving patient outcomes.